FIELD: medicine.
SUBSTANCE: content of mean molecules and carbonyl products of oxidative protein modification. If their relation is <0.4, the absence of resistance is stated, while the value is >0.4 shows the presence of treatment resistance.
EFFECT: use of the method enables accurately detected treatment-resistant patients suffering advanced chronic dermatoses.
1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING DEGREE OF ENDOGENOUS INTOXICATION OF ORGANISM AT SICK OF WIDESPREAD CHRONIC DERMATOSES | 2006 |
|
RU2333496C1 |
| METHOD FOR TREATING PATIENTS FOR ACANTHOLYTIC BLADDERWORT | 2006 |
|
RU2321395C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 PSORIASIS IN POSTMENOPAUSAL WOMEN | 2018 |
|
RU2684287C1 |
| METHOD FOR PREDICTION OF EPILEPSY SEVERITY | 2012 |
|
RU2499262C1 |
| METHOD FOR TREATING PAINFUL STATES IN THE MAXILLOFACIAL AREA | 2000 |
|
RU2177269C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PURULENT AND SEROUS MENINGITES IN CHILDREN | 2012 |
|
RU2499995C1 |
| METHOD FOR EARLY PREDICTION OF THE RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2022 |
|
RU2793531C1 |
| APPLICATION OF SELECTIVE IMMUNOSORBENT FOR REMOVAL OF ANTIBODIES TO TYPE 3 DESMOGLEIN FROM BLOOD SERUM OF PATIENTS WITH VESICULAR FEVER | 2016 |
|
RU2627652C1 |
| METHOD FOR TREATING PATIENTS WITH PSORIASIS | 2002 |
|
RU2224515C2 |
| METHOD FOR TREATING THE CASES OF ENDOGENOUS CEREBRAL DISEASES | 1999 |
|
RU2173552C2 |
